DEA Schedule CII

Strength

3.75; 3.75; 3.75; 3.75 mg/1; mg/1; mg/1; mg/1

NDC

00115148801

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Last Updated

4/22/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA076852

On Market Since

2/16/2016

Pharmacological Classes

Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulation
Central Nervous System Stimulation
Central Nervous System Stimulation
Central Nervous System Stimulation

Price History

1W

0.0%

1M

-2.0%

3M

-4.1%

6M

+7.4%

1Y

-12.8%

3Y

-23.5%

5Y

-15.8%

All

-82.1%